Literature DB >> 22580989

The Ex Vivo Eye Irritation Test (EVEIT) in evaluation of artificial tears: Purite-preserved versus unpreserved eye drops.

N Schrage1, M Frentz, F Spoeler.   

Abstract

OBJECTIVE: Preservatives in artificial tears cause controversy. New developments such as the Purite system have been introduced into the market, with the promise of little damage to the corneal surface. We wanted to give insight into the differences in the effect of preserved and unpreserved artifical tears on rabbit corneas cultured with the Ex Vivo Eye Irritation Test (EVEIT) system. MATERIALS: We compared the two artifical tears products Hylo Comod and Optive being dropped for 72 hours each hour one drop onto the corneal surface.
METHODS: Each cornea was mechanically wounded with four epithelial defects on each cornea with a size of 3 to 4.5 mm(2). With n = 4 corneas in the Hylo-Comod and n = 4 corneas in the Optive group, we exposed the corneal surfaces to repeated doses of these artificial tears for 3 days. We observed healing of corneal erosions and surface epithelial integrity with sodium-fluoresceine staining under cobalt blue light illumination.
RESULTS: We found nearly complete healing of epithelial defects with both artificial tears. The Hylo-Comod group healed significantly faster. After 72 hours, the vast majority of epithelial defects were closed. All corneas exposed to Purite showed superficial stippling, whereas the HyloComod group did not show any stippling of the cornea; this difference was significant. DISCUSSION: Epithelial healing and recovery in the EVEIT system is observed in both groups, confirming the concept of artificial tears as a supporting factor of corneal health and healing. The superficial stippling of the corneal epithelium was observed only in the Optive group. This effect is considered as a marker of dry eye syndrome, and should be prevented by the application of artificial tears. Preservative-free eye drops such as HyloComod improve healing, and prevent symptoms of dry eye syndrome in the EVEITsystem. Compared to EVEIT results of former experiments with benzalconium chloride-preserved eye drops, Optive promoted healing of corneal erosions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22580989     DOI: 10.1007/s00417-012-1999-3

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  16 in total

Review 1.  [Preservatives in eye drops: toward awareness of their toxicity].

Authors:  D Vaede; C Baudouin; J-M Warnet; F Brignole-Baudouin
Journal:  J Fr Ophtalmol       Date:  2010-09-15       Impact factor: 0.818

2.  Towards a new in vitro model of dry eye: the Ex Vivo Eye Irritation Test.

Authors:  Felix Spöler; Markus Frentz; Norbert F Schrage
Journal:  Dev Ophthalmol       Date:  2010-05-18

3.  Repeated exposure to benzalkonium chloride in the Ex Vivo Eye Irritation Test (EVEIT): observation of isolated corneal damage and healing.

Authors:  Markus Frentz; Miriam Goss; Martin Reim; Norbert F Schrage
Journal:  Altern Lab Anim       Date:  2008-02       Impact factor: 1.303

4.  Efficacy of sodium hyaluronate and carboxymethylcellulose in treating mild to moderate dry eye disease.

Authors:  Ji Hwan Lee; Hyun Suk Ahn; Eung Kweon Kim; Tae-Im Kim
Journal:  Cornea       Date:  2011-02       Impact factor: 2.651

5.  Changing the composition of buffered eye-drops prevents undesired side effects.

Authors:  Norbert F Schrage; Markus Frentz; Martin Reim
Journal:  Br J Ophthalmol       Date:  2010-07-21       Impact factor: 4.638

6.  Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies.

Authors:  A C Poon; G Geerling; J K Dart; G E Fraenkel; J T Daniels
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

7.  Fluorescein punctate staining traced to superficial corneal epithelial cells by impression cytology and confocal microscopy.

Authors:  Maryam Mokhtarzadeh; Richard Casey; Ben J Glasgow
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-05       Impact factor: 4.799

8.  Clinical trials of therapeutic ocular surface medium for moderate to severe dry eye.

Authors:  Stephanie L Watson; Julie T Daniels; Gerd Geerling; John Kg Dart
Journal:  Cornea       Date:  2010-11       Impact factor: 2.651

9.  Hydrogen peroxide-mediated corneal endothelial damage. Induction by oxygen free radical.

Authors:  D S Hull; K Green; L Thomas; N Alderman
Journal:  Invest Ophthalmol Vis Sci       Date:  1984-11       Impact factor: 4.799

10.  Artificial tear composition and promotion of recovery of the damaged corneal epithelium.

Authors:  D Lopez Bernal; J L Ubels
Journal:  Cornea       Date:  1993-03       Impact factor: 2.651

View more
  7 in total

1.  [Pharmacokinetics of the anterior eye].

Authors:  K Bell; N Pfeiffer; F H Grus
Journal:  Ophthalmologe       Date:  2014-02       Impact factor: 1.059

2.  Porcine Corneas Incubated at Low Humidity Present Characteristic Features Found in Dry Eye Disease.

Authors:  Alice Rocha Teixeira Netto; José Hurst; Karl-Ulrich Bartz-Schmidt; Sven Schnichels
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

3.  Impact of polyethylene glycol 400/propylene glycol/hydroxypropyl-guar and 0.1% sodium hyaluronate on postoperative discomfort following cataract extraction surgery: a comparative study.

Authors:  Georgios Labiris; Panagiota Ntonti; Haris Sideroudi; Vassilios Kozobolis
Journal:  Eye Vis (Lond)       Date:  2017-05-10

4.  The use of preservatives in dry eye drops.

Authors:  Karen Walsh; Lyndon Jones
Journal:  Clin Ophthalmol       Date:  2019-08-01

5.  Epithelial Regeneration in Human Corneas Preserved in an Active Storage Machine.

Authors:  Damien Guindolet; Emmanuel Crouzet; Zhiguo He; Pascal Herbepin; Chantal Perrache; Thibaud Garcin; Anne-Sophie Gauthier; Fabien Forest; Michel Peoc'h; Philippe Gain; Eric Gabison; Gilles Thuret
Journal:  Transl Vis Sci Technol       Date:  2021-02-05       Impact factor: 3.283

Review 6.  Artificial Tears: Biological Role of Their Ingredients in the Management of Dry Eye Disease.

Authors:  Marc Labetoulle; Jose Manuel Benitez-Del-Castillo; Stefano Barabino; Rocio Herrero Vanrell; Philippe Daull; Jean-Sebastien Garrigue; Maurizio Rolando
Journal:  Int J Mol Sci       Date:  2022-02-23       Impact factor: 5.923

Review 7.  Ocular benzalkonium chloride exposure: problems and solutions.

Authors:  Michael H Goldstein; Fabiana Q Silva; Nysha Blender; Trung Tran; Srilatha Vantipalli
Journal:  Eye (Lond)       Date:  2021-07-14       Impact factor: 4.456

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.